Transcription factor activating protein-2β: A positive regulator of monocyte chemoattractant protein-1 gene expression

Endocrinology

Volumn 150, Issue 4, 2009, Pages 1654-1661

  Kondo, Motoyuki ^a   Maegawa, Hiroshi ^a   Obata, Toshiyuki ^a   Ugi, Satoshi ^a   Ikeda, Kazuhiro ^a   Morino, Katsutaro ^a   Nakai, Yukie ^a   Nishio, Yoshihiko ^a   Maeda, Shiro ^b   Kashiwagi, Atsunori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2BETA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE;

3T3-L1 CELLS; ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CHEMOKINE CCL2; CHROMATIN IMMUNOPRECIPITATION; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; MICE; PLASMIDS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-2;

EID: 63849109129     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1361     Document Type: Article

References (41)

1. Maeda S, Tsukada S, Kanazawa A, Sekine A, Tsunoda T, Koya D, Maegawa H, Kashiwagi A, Babazono T, Matsuda M, Tanaka Y, Fujioka T, Hirose H, Eguchi T, Ohno Y, Groves CJ, Hattersley AT, Hitman GA, Walker M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Kamatani N, McCarthy MI, Na- kamura Y 2005 Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. J Hum Genet 50:283-292
2. Tsukada S, Tanaka Y, Maegawa H, Kashiwagi A, Kawamori R, Maeda S 2006 Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes. Mol Endocrinol 20:1104-1111
3. Tao Y, Maegawa H, Ugi S, Ikeda K, Nagai Y, Egawa K, Nakamura T, Tsukada S, Nishio Y, Maeda S, Kashiwagi A 2006 The transcription factor AP-2β causes cell enlargement and insulin resistance in 3T3-L1 adipocytes. Endocrinology 147:1685-1696
4. Matsuzawa Y 2005 Adipocytokines and metabolic syndrome. Semin Vasc Med 5:34 -39
5. Ahima RS, Lazar MA 2008 Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 22:1023-1031
6. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R 2003 Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) 228:1111-1117
7. Ikeda K, Maegawa H, Ugi S, Tao Y, Nishio Y, Tsukada S, Maeda S, Kashiwagi A 2006 Transcription factor activating enhancer-binding protein-2β. A negative regulator of adiponectin gene expression. J Biol Chem 281:31245-31253
8. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M 2006 MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116:1494 -1505
9. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka- Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T 2006 Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281:26602-26614
10. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897
11. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830
12. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, LeibelRL, Ferrante JrAW2006 CCR2 modulates inflammatoryand metabolic effects of high-fat feeding. J Clin Invest 116:115-124
13. Kirk EA, Sagawa ZK, McDonald TO, O'Brien KD, Heinecke JW 2008 MCP-1 deficiency fails to restrain macrophage infiltration into adipose tissue. Diabetes 57:1254 -1261
14. Ping D, Boekhoudt GH, Rogers EM, Boss JM 1999 Nuclear factor-κB p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J Immunol 162:727-734
15. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R 2004 Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 317:598 -604
16. Yoshimura H, Nakahama K, Safronova O, Tanaka N, Muneta T, Morita I 2006 Transforming growth factor-β stimulates IL-1β-induced monocyte che- moattractant protein-1 expression in human synovial cells via the ERK/AP-1 pathway. Inflamm Res 55:543-549
17. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, KashiwagiA, Olefsky JM 2004 Protein phosphatase 2Anegativelyregulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 24:8778 -8789
18. Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A 2001 Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells. J Biol Chem 276:10207-10211
19. Egawa K, Sharma PM, Nakashima N, Huang Y, Huver E, Boss GR, Olefsky JM 1999 Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J Biol Chem 274:14306 -14314
20. Hashimoto T, Nakamura T, Maegawa H, Nishio Y, Egawa K, Kashiwagi A 2005 Regulation of ATP-sensitive potassium channel subunit Kir6.2 expression in rat intestinal insulin-producing progenitor cells. J Biol Chem 280:1893-1900
21. Latasa MJ, Griffin MJ, Moon YS, Kang C, Sul HS 2003 Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals. Mol Cell Biol 23:5896 -5907
22. Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, Pierpont ME, Gelb BD 2000 Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet 25:42-46
23. Zhao F, Weismann CG, Satoda M, Pierpont ME, Sweeney E, Thompson EM, Gelb BD 2001 Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation. Am J Hum Genet 69:695-703
24. Tummala R, Romano RA, Fuchs E, Sinha S 2003 Molecular cloning and characterization of AP-2ε, a fifth member of the AP-2 family. Gene 321:93-102
25. Williams T, Admon A, Luscher B, Tjian R 1988 Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2:1557-1569
26. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD 2001 Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2ΔA, with unique DNA binding and transactivation properties. J Biol Chem 276:40755-40760
27. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F, Hof- stadter F, Schule R, Buettner R 1995 Cloning and characterization of a second AP-2 transcription factor: AP-2βμ. Development 121:2779-2788
28. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC 1996 A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13:1701-1707
29. Sekine O, Nishio Y, Egawa K, Nakamura T, Maegawa H, Kashiwagi A 2002 Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 277:36631-36639
30. Sartipy P, Loskutoff DJ 2003 Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100:7265-7270
31. Guilherme A, Virbasius JV, Puri V, Czech MP 2008 Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377
32. Wang D, Shin TH, Kudlow JE 1997 Transcription factor AP-2 controls transcription of the human transforming growth factor-α gene. J Biol Chem 272:14244 -14250
33. McPherson LA, Baichwal VR, Weigel RJ 1997 Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci USA 94:4342-4347
34. Perkins ND, Agranoff AB, Duckett CS, Nabel GJ 1994 Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression. J Virol 68:6820-6823
35. Muchardt C, Seeler JS, Nirula A, Gong S, Gaynor R 1992 Transcription factor AP-2 activates gene expression of HTLV-I. EMBO J 11:2573-2581
36. Muchardt C, Seeler JS, Gaynor RB 1992 Regulation of HTLV-I gene expression by tax and AP-2. New Biol 4:541-550
37. Frisch SM, Morisaki JH 1990 Positive and negative transcriptional elements of the human type IV collagenase gene. Mol Cell Biol 10:6524 -6532
38. Bosher JM, Williams T, Hurst HC 1995 The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92:744 -747
39. Duan C, Clemmons DR 1995 Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem 270:24844 -24851
40. Jiang MS, Tang QQ, McLenithan J, Geiman D, Shillinglaw W, Henzel WJ, Lane MD 1998 Derepression of the C/EBPα gene during adipogenesis: identification of AP-2α as a repressor. Proc Natl Acad Sci USA 95:3467-3471
41. Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M 1995 Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J 14:1508 -1519